Earnings Feed
Start Free
ALEXION PHARMACEUTICALS INC·4

Feb 6, 5:43 PM ET

Coissac Patrice 4

4 · ALEXION PHARMACEUTICALS INC · Filed Feb 6, 2012

Insider Transaction Report

Form 4
Period: 2012-02-03
ALEXION PHARMACEUTICALS INCALXN
Coissac Patrice
GM/President ALXN SAS Europe
Transactions
  • Exercise/Conversion

    Option to Purchase Common Stock

    2012-02-03+64,000→ 64,000 total
    Exercise: $78.88From: 2012-05-03Exp: 2022-02-03→ Common Stock, par value $.0001 per share (64,000 underlying)
  • Exercise/Conversion

    Common Stock, par value $.0001 per share

    2012-02-03+8,000→ 85,882 total
Footnotes (2)
  • [F1]Award of Restricted Stock Units pursuant to 2004 Incentive Plan. 50% vests on two year anniversary of grant date and 1/8 vests every 6 months thereafter.
  • [F2]1/16 vests every three months following grant date.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT